Impact of Consumption of Cowpea Leaves on Blood Glucose

May 8, 2023 updated by: Charlotte E Mills, University of Reading

Intake of foods high in carbohydrates causes a spike in glucose in the blood. Repeated high blood glucose spikes are associated with an increased risk of diabetes. Polyphenols, which are abundant in vegetables, may influence how the body utilises carbohydrates. Cowpea, also referred to as black-eyed peas (Vigna unguiculata (L.) Walp.) leaves, contain polyphenols and fibre that can help regulate blood glucose.

The study will be an acute, single-blind, randomised control trial with a cross-over design involving healthy black participants aged ≥18 years. This clinical trial aims to investigate if consuming cowpea leaves can reduce blood glucose spikes after consuming a meal high in carbohydrates. Participants will be randomised to consume either bread with jam containing freeze-dried cowpea leaves (active intervention) or jam without any freeze-dried powder (control group). Blood glucose will be monitored before the intervention and every 15 minutes after the intervention using a continuous glucose monitor.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adults aged ≥ 18 years
  • Participants from Black, Black British, Caribbean or African ethnic backgrounds,which includes: Caribbean, African, Any other Black, Black British, or Caribbean background
  • Should be able to give informed consent
  • Should be willing to provide GP's contact details

Exclusion Criteria:

  • Pregnant or lactating mothers
  • Special dietary requirements such as vegetarians and vegans
  • Participants who are on a specialised diet such as a weight reduction diet
  • Having any chronic illness or taking medication for chronic illness
  • Participants whose blood results indicate illness
  • Participants on mediation for hypertension or hyperlipidaemia
  • Sportsmen or women or vigorous exercise for more than 5 times per week
  • Alcohol (more than 14 units per week) or drug abusers.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Freeze dried cowpea leaves mixed in jam
6g of freeze-dried cowpea leaves (equivalent to one portion of vegetables) mixed with apricot jam and spread on bread.
6g of freeze-dried cowpea leaves, equivalent to 80g(a portion) of vegetables mixed with Jam and spread on bread
Active Comparator: Jam with green food colour
Apricot jam mixed with green colouring and spread on bread
Jam with green food colouring spread on bread

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in blood glucose
Time Frame: At baseline (t=0 hours) and 15 minutes interval until (t=3 hours)
Blood glucose measured by continous glucose monitor
At baseline (t=0 hours) and 15 minutes interval until (t=3 hours)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in blood pressure
Time Frame: At baseline (t=0 hours) and every 30 minute until (t=3 hours)
Systolic and diastolic blood pressure by blood pressure monitor
At baseline (t=0 hours) and every 30 minute until (t=3 hours)
Microvascular blood flow
Time Frame: At baseline (t=0 hours) and (t=2.5 hours)
Microvascular blood flow using Laser doppler Imaging with Iontophoresis
At baseline (t=0 hours) and (t=2.5 hours)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2023

Primary Completion (Anticipated)

July 30, 2023

Study Completion (Anticipated)

July 30, 2023

Study Registration Dates

First Submitted

February 19, 2023

First Submitted That Met QC Criteria

February 19, 2023

First Posted (Actual)

March 1, 2023

Study Record Updates

Last Update Posted (Actual)

May 10, 2023

Last Update Submitted That Met QC Criteria

May 8, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 06/2023

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Glucose

Clinical Trials on Cowpea leaves mixed with Jam

3
Subscribe